Mark Napoli
Impact in
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
-
- Lipoproteins and Cardiovascular Health
- Coronary Interventions and Diagnostics
Papers in
-
- Heart Failure Treatment and Management 4
- Antiplatelet Therapy and Cardiovascular Diseases 2
- Renin-Angiotensin System Studies 1
- Surgery 1
- Lipoproteins and Cardiovascular Health 1
- Co-authors
- E. Magnus Ohman (1 shared paper)Ross J. Simpson (1 shared paper)Stephan Moll (1 shared paper)Jana Hirmerová (1 shared paper)George A. Stouffer (1 shared paper)
- Journals
- The Lancet (3 papers)Circulation Heart Failure (1 paper)Journal of the American College of Cardiology (1 paper)European Journal of Heart Failure (1 paper)JAMA Cardiology (1 paper)
- Partner nations
- United StatesCzechia
In The Last Decade
Mark Napoli
6 papers receiving 411 citations
Mark Napoli's Hit Papers
Peers
Comparison fields: 5 of 31
- Cardiology and Cardiovascular Medicine 202
- Surgery 201
- Family Practice 7
- Endocrinology, Diabetes and Metabolism 24
- Nephrology 9
Countries citing papers authored by Mark Napoli
This map shows the geographic impact of Mark Napoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Napoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Napoli more than expected).
Fields of papers citing papers by Mark Napoli
This network shows the impact of papers produced by Mark Napoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Napoli. The network helps show where Mark Napoli may publish in the future.
Co-authors
The 5 scholars most cited alongside Mark Napoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US Hit paper breakdown → | 2021 | 182 |
| 2 | 2019 | 160 | |
| 3 | Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial Hit paper breakdown → | 2025 | 41 |
| 4 | 2004 | 22 | |
| 5 | 2025 | 19 | |
| 6 | 2021 | 11 | |
| 7 | 2026 | 0 | |
| 8 | 2026 | 0 |
About Mark Napoli
Mark Napoli is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 8 papers that have together received 435 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Lipoproteins and Cardiovascular Health (1 paper) and Renin-Angiotensin System Studies (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (202 citations), Surgery (201 citations), Family Practice (7 citations), Endocrinology, Diabetes and Metabolism (24 citations) and Nephrology (9 citations). Mark Napoli has collaborated with scholars based in United States and Czechia. Frequent co-authors include E. Magnus Ohman, Ross J. Simpson, Stephan Moll, Jana Hirmerová and George A. Stouffer. Their work appears in journals such as The Lancet, Circulation Heart Failure, Journal of the American College of Cardiology, European Journal of Heart Failure and JAMA Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.